|
|
| |
|
Ronald L. Heimark, PhD
Chief, Section of Surgical Research
Professor of Surgery
Professor of Pathology
Professor of Cell Biology & Anatomy
Arizona Health Sciences Center
Department of Surgery
1501 N. Campbell Avenue, Rm. 5309
PO Box 245112
Tucson, AZ 85724-5084
Office Phone: (520) 626-1913
Email: rheimark@u.arizona.edu
|

|
| |
| Education |
|
BA:
|
1970,
Biology and Chemistry, Western Washington State University,
Bellingham, WA |
|
PhD:
|
1976,
Biochemistry, University of California, Davis |
|
Fellowships:
|
1976,
Biochemistry, University of Washington, Seattle |
|
1981,
Pathology, University of Washington, Seattle |
|
|
|
| Research
The regulatory processes underlying the transformation of epithelium
to mesenchyme in embryonic development and cancer are not well
understood. Cell transformation is mediated by cell-cell interactions
between different tissues and the signaling between tissues is
mainly through growth factors and cell adhesion molecules. Growth
factors activate signal transduction pathways and initiate gene
expression cascades that result in the change in phenotype, such
as changes in the cadherin family of cell-cell adhesion molecules.
Intercellular communication maintains tissue homeostasis through
tightly balanced regulation of cell survival and cell growth.
Our studies have focused on the roles of
cadherins and catenins in the transformation of epithelium to
mesenchyme during progression of prostate cancer, and in the differentiation
of mesenchymal cells from endothelium to form heart valves. Common
signaling pathways are shared in cell transformation during metastasis
and transformation of cardiac endothelial cells into mesenchyme
of the valves and walls of the heart. In prostate carcinoma progression,
we described a switch from E-cadherin to N-cadherin, which is
linked to malignancy. Identification of the role of cadherins
and characterization of the mechanisms for their contribution
to metastasis is one important area of prostate cancer research
because these studies are generating information for the improvement
of diagnosis and therapy of prostate cancer. Thus, exploring mechanisms
for N-cadherin mediated gene expression program is to understand
the molecular mechanisms signaling in malignant prostate carcinoma.
This may explain in part one of the crucial steps to metastasis,
a fundamental concept in cancer biology, which has yet to be explained
at the molecular level. An additional research focus is on the
Pathogenesis of Vascular Occlusive Disease. Blood vessels are
dynamic structures, being able to make rapid and lasting changes
in vessel structure and function and our research is using molecular
cellular and genetic approaches to investigate SMC cadherins in
critical roles of cell-cell adhesion and cell signaling during
neointima formation by SMCs.
Selected Publications
- Tran NL, Adams
DG, Vaillincourt RL, and Heimark RL. 2002. Signaling from N-cadherin
increases Bcl-2 through a Phosphatidylinositol 3-Kinase/Akt
Pathway. Journal of Biological Chemistry (in press).
- Tran NL, Cress
AE, Nagle RB, and Heimark RL. 1999. N-cadherin Expression in
Human Prostate Carcinoma Cell Lines: An Epithelial-Mesenchymal
Transformation Mediating Adhesion with Stromal Cells. American
Journal of Pathology 155: 787-798.
- Wong R, Baldwin
AL, and Heimark RL: 1999. Cadherin 5 redistribution at sites
of TNFalpha and gama IFN induced macromolecular permeability
in mesenteric venules. American Journal of Physiology, Heart
and Circulatory Physiology 276: H736-748.
- Westerband A,
Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, Mills
JL, Hunter GC, Heimark RL. 2001. Vein adaptation to arterialization
in an experimental model. J Vasc Surg. 561-569.
- Haselton FR and
Heimark RL. 1997. Role of cadherins 5 and 13 in the aortic endothelial
barrier. J Cellular Physiol. 171: 243-251.
|
|
 |